-

cGMP Regulatory Inspections Through the Eyes of FDA, EMA and PMDA: 1 Day Virtual Course (Nov 13, 2025) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "cGMP Regulatory Inspections - Through the Eyes of FDA, EMA and PMDA (Nov 13, 2025)" training has been added to ResearchAndMarkets.com's offering.

cGMP or current good manufacturing practices are not limited to product development and monitoring of the SOPs. Everything plays an essential role, starting from the design of the facility, the strength of the unit, and the purity of the components.

Do you have the proficiency to update cGMP to its core? You will, after attending this cGMP training! The core purpose of this seminar is to establish a robust idea of how the quality of active pharmaceutical ingredients.

Course Overview

Do you think a consumer will be able to assess the quality of the drug? This is difficult by just smelling, touching, or looking at the final product. Hence, you need thorough pharmaceutical GMP training to ensure every consumer receives high-quality drugs.

Since a basic cGMP course is not sufficient to ensure quality, the effort is to improve the overall conditions under which a pharmaceutical product is manufactured. As a result, you will see a dip in cGMP violations, and the operations will improve significantly.

As per FDA GMP inspection guidelines, here are some controls they focus on:

  • Improving management systems
  • Reliable testing of the samples, raw materials, and final products
  • Developing strict operating procedures
  • Consistent work on reducing the deviations
  • Procuring quality raw materials
  • Thorough investigations of the deviations

By adhering to this FDA GMP inspection checklist, you can avoid the most common quality failures in your manufacturing unit. The 58-page document on cGMP has excellent updates which will be discussed in this cGMP training.

People Also Ask

Q1 Does this cGMP training explain how FDA inspects a facility?

Yes. Since FDA GMP inspection checklist has a standard protocol, your faculty will discuss it thoroughly. In addition, this cGMP training will also guide you to produce failure reports strategically in your favor and get approval from inspectors. Most senior professionals who attended this cGMP course have managed to receive a green signal in the FDA GMP inspection.

Q2 Does this seminar help professionals from new companies learn about cGMPs?

Yes. This cGMP online training includes a detailed discussion of recent guidelines and regulation documents released by the FDA. You will also get to know what FDA currently expects from the companies and why. Additionally, your faculty will share multiple resources that will help you build a company that complies with cGMP regulations to the edge.

Q3 What if the company is found to be non-compliant with cGMP guidelines? Can senior managers and project associates get help from this seminar?

Yes. Your faculty will thoroughly discuss cGMP violations and their nature to make you understand why your company was non-compliant. The violations could be due to labeling failures or inefficiency in the manufacturing process. This seminar will give you a broader perspective to tackle this situation and improve the overall operation.

Who Should Attend:

cGMP training is suitable for professionals from all verticals of a manufacturing unit. No matter how new you are to the industry, pharmaceutical GMP training will help you deliver the best possible work.

To further clarify the relevance of cGMP online training for professionals, here is a list of beneficiaries:

  • R&D Associates and Research Scholars: Helps you understand the basic laboratory norms and pass the FDA GMP inspection with the best ratings.
  • IT Subject Matter Experts: Makes you thorough with production facility protocols, equipment, tools, and machines. This guarantees better execution of technical knowledge by adhering to standard norms.
  • Contract Laboratories: Empowers lab technicians with the knowledge of handling and storage of raw materials, sanitation and hygiene, quality control, and structuring of the lab.
  • Regulatory Affairs Personnel: Gives you a standard manual to audit or investigate the laboratories and production units. Furthermore, allows you to conduct a thorough inspection at reputed laboratories.
  • Senior Management: Provides you with a handbook of FDA GMP inspection checklist to observe the operations. You can also interrupt or change an SOP to improve the quality of the final product.

Key Topics Covered:

Session 1:

U.S., EU, and Japan GMPs - Status of Harmonization& Future Trends

  • Current status of harmonization of GMP requirements
  • Future Trends

Where Inconsistencies Become a Problem: WHO, ICH, Countries

  • Discrepancies in global expectations
  • Alignment issues

Key Chapter Reviews

  • ICH GMP organization
  • Category reviews

Compliance with ICH Guidelines for GMPs

  • Understanding and Insight into Healthcare Authority expectations
  • How GMP requirements/inspections can differ with a single ICH Standard
  • How regulators (from 3 regions) will assess/enforce compliance with Q7

Session 2:

APIs

  • Auditing API facilities
  • Typical audit agenda
  • ICH Area differences

Finished Products

  • Auditing finished product facilities
  • Typical audit agenda
  • ICH Area differences

Excipients

Sterile products

Biologics

Clinical Packaging

Session 3:

Area GMP Inspections

  • Differences on how GMP inspections are conducted
  • Areas of GMP inspection focus by area
  • Modifying your self-inspection systems to customized area concerns

Outsourcing Management Regional Perspective on:

  • Contract manufacturing
  • Contract packaging.
  • 3rd Party Contract testing

Auditing Your Facilities for Global Considerations

  • Importance of pre-audits to regional GMP focus.
  • How to focus your internal audits to a US, EU and Japan compliance system.

Speakers:

Kelly Thomas

Vice President

Stallergenes Greer

Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.

Utilizing strategic thinking, risk based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.

For more information about this training visit https://www.researchandmarkets.com/r/4kavak

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Biocompatibility Testing Market Worth $3.42 Billion in 2025 is Forecast to Reach $6.4 Billion by 2032 - Rapid Emergence of Innovative Biomaterials Driving the Industry at 9.32% CAGR - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Biocompatibility Testing Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. Senior executives in healthcare face evolving challenges as biocompatibility testing becomes increasingly central to regulatory strategy, risk management, and operational planning. Understanding market developments and leveraging insights are essential for maintaining compliance and supporting innovation within complex environments. Market Snapsh...

Ultrasound Coaxial Cable Market Intelligence Report 2025-2032 - Development of Flexible Miniature Coaxial Cables for Endoscopic Ultrasound Applications Presents Opportunities - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Ultrasound Coaxial Cable Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The ultrasound coaxial cable market is evolving as a vital enabler of high-performance imaging and communication systems across healthcare and defense. Executive stakeholders require precise, actionable insights to navigate this technologically advanced and highly regulated sector. Market Snapshot: Ultrasound Coaxial Cable Market The ultrasound c...

Process Analytical Technology Market and Competition Forecast 2025-2032 Featuring ABB, Emerson Electric Co., Endress+Hauser, Thermo Fisher Scientific, Agilent Technologies, Schneider Electric and More - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Process Analytical Technology Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. Process analytical technology is redefining quality assurance for manufacturing leaders across life sciences, industrial, and food sectors, driving next-generation process efficiency and real-time compliance. Senior decision-makers evaluating innovation strategies will find this report essential for aligning technology investments to evolvin...
Back to Newsroom